Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
3.780
+0.060 (1.61%)
Jul 16, 2025, 10:23 AM - Market open

UPC Revenue

Universe Pharmaceuticals INC had revenue of $9.15M in the half year ending March 31, 2025, a decrease of -50.44%. This brings the company's revenue in the last twelve months to $19.29M, down -27.81% year-over-year. In the fiscal year ending September 30, 2024, Universe Pharmaceuticals INC had annual revenue of $23.02M, down -28.74%.

Revenue (ttm)
$19.29M
Revenue Growth
-27.81%
P/S Ratio
0.04
Revenue / Employee
$85,747
Employees
225
Market Cap
2.13M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202423.02M-9.28M-28.74%
Sep 30, 202332.31M-7.83M-19.52%
Sep 30, 202240.14M-7.84M-16.34%
Sep 30, 202147.98M17.28M56.27%
Sep 30, 202030.70M-2.53M-7.60%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group410.06B
Johnson & Johnson89.33B
Merck & Co.63.92B
AbbVie57.37B
AstraZeneca54.98B
Novartis AG53.22B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings